In the last three months, 11 analysts have published ratings on Albemarle ALB, offering a diverse range of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 2 | 8 | 1 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 0 | 1 | 4 | 0 | 0 |
2M Ago | 0 | 1 | 2 | 0 | 0 |
3M Ago | 0 | 0 | 1 | 1 | 0 |
Analysts have set 12-month price targets for Albemarle, revealing an average target of $144.18, a high estimate of $199.00, and a low estimate of $120.00. A 14.84% drop is evident in the current average compared to the previous average price target of $169.30.
Interpreting Analyst Ratings: A Closer Look
The standing of Albemarle among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Joshua Spector | UBS | Lowers | Neutral | $125.00 | $137.00 |
Patrick Cunningham | Citigroup | Lowers | Neutral | $120.00 | $175.00 |
Joshua Spector | UBS | Lowers | Neutral | $137.00 | $142.00 |
David Deckelbaum | TD Cowen | Announces | Market Perform | $130.00 | - |
Christopher Parkinson | Mizuho | Lowers | Neutral | $130.00 | $152.00 |
Colin Rusch | Oppenheimer | Lowers | Outperform | $191.00 | $308.00 |
Joshua Spector | UBS | Raises | Neutral | $142.00 | $130.00 |
Corinne Blanchard | Deutsche Bank | Lowers | Hold | $135.00 | $155.00 |
Aleksey Yefremov | Keybanc | Lowers | Overweight | $199.00 | $200.00 |
Matthew DeYoe | B of A Securities | Lowers | Neutral | $149.00 | $154.00 |
Charles Neivert | Piper Sandler | Lowers | Underweight | $128.00 | $140.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Albemarle. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Albemarle compared to the broader market.
- Price Targets: Gaining insights, analysts provide estimates for the future value of Albemarle's stock. This comparison reveals trends in analysts' expectations over time.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Albemarle's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Albemarle analyst ratings.
All You Need to Know About Albemarle
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the U.S. and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the U.S., Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.
A Deep Dive into Albemarle's Financials
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: Albemarle displayed positive results in 3 months. As of 30 September, 2023, the company achieved a solid revenue growth rate of approximately 10.46%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Net Margin: Albemarle's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 13.09%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Albemarle's ROE excels beyond industry benchmarks, reaching 3.07%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.59%, the company showcases effective utilization of assets.
Debt Management: Albemarle's debt-to-equity ratio is below the industry average at 0.37, reflecting a lower dependency on debt financing and a more conservative financial approach.
The Core of Analyst Ratings: What Every Investor Should Know
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.